BioRad QX700 E Droplet Digital PCR System

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98027Q00057

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6515

Additional Details
Set Aside

None

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), has issued a combined synopsis/solicitation for the acquisition of a BioRad QX700 E Droplet Digital PCR System. This procurement is being conducted on a sole-source basis under FAR 6.302-1, as BioRad Laboratories, Inc. is identified as the only responsible source capable of meeting the Government’s minimum technical requirements for this specialized equipment. The primary objective of this procurement is to equip the Division of Translational Medicine’s (DTM) shared laboratories in Bethesda, Maryland, with a state-of-the-art digital PCR system that enables absolute quantification of nucleic acids. The QX700 E Droplet Digital PCR System is integral to ongoing experiments that demand highly precise assessment of sample quality and quantity. Its advanced capabilities—such as absolute quantification without the need for standard curves, 7-color multiplexing, and intuitive, user-friendly software—are designed to streamline workflows and enhance the accessibility of digital PCR for low-throughput or ad hoc studies in shared research environments. Key features and requirements of the system include: - All-in-one, integrated instrument supporting walkaway operation for increased efficiency. - Intuitive software interface for straightforward run setup and data analysis. - Capability to process 16, 32, or up to 48 samples per run, providing flexibility for laboratories with varying throughput needs. - Compact design suitable for shared research spaces and low-throughput applications. - Exclusive use of Droplet Digital PCR technology for absolute quantification of nucleic acids. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a Product Service Code of 6515, and is classified under the 2022 NAICS version. The place of performance is Bethesda, Maryland, United States. This notice is not a request for competitive quotations; however, the Government invites interested parties who believe they can meet the specified technical and operational requirements to submit a capability statement. Such statements must be submitted electronically to the primary contact, Roshonna Davis ([email protected]), no later than 9:00 a.m. EDT on November 18, 2026. All submissions should reference Notice No. 75N98027Q00057 in the subject line. The Government will review all timely responses to determine if the acquisition should remain a sole-source procurement or be opened to competition. An award is anticipated approximately five calendar days after the closing date, unless a qualified alternative source is identified. The contracting entity for this procurement is the NIH Office of Logistics and Acquisition Operations (OLAO), operating under the Department of Health and Human Services. The opportunity remains active and is posted on SAM.gov under Opportunity ID bbbb9d2669114e36b1b58d97c8fe317c. Contractors with expertise in analytical laboratory instrument manufacturing, particularly those capable of providing or supporting the BioRad QX700 E Droplet Digital PCR System, are encouraged to review the full notice and consider submitting a capability statement if they can meet the Government’s requirements.